References
- Lim VK, Halijah MY. In vitro activity of sulperazon against recent isolates of ceftazidime-resistant bacteria. Med J Malaysia 2001; 56: 365–9.
- Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transfer-able resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pat-terns. Rev Infect Dis 1988; 10: 867–78.
- Hupková M, Blahová J, Kr6mêry V (Sr.), Králiková K. Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their produc-tion of extended-spectrum beta-lactamase in Slovakia. J Chemother 1995, 7: 16-20.
- Knothe H, Shah P, Kr6mêry V, Antal L, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315–7.
- Neu HC. Antibiotic bacterial resistance. In: Lorian V (ed.): Antibiotics in Laboratory Medicine (2. edition), Baltimore, Williams and Wilkins, 1986: 762-5.
- Blahová J, Hupková M, Králiková K, Kr6mêry V, Ligková A, Kubofiová K. Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase pro-ductions in Klebsiella pneumoniae strains from infected neonates. Zentralbl Bakteriol 1998; 288: 75–86.
- Yucesoy M, Yulug N, Kocagoz S, Unal S, Cetin S, Calangu S. Antimicrobial resistance of gram-negative isolates from intensive care units in Turkey: comparison to previous three years. J Chemother 2000, 12: 294–8.
- Medeiros AA. Evolution and dissemination of beta-lacta-mases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis 1997; 24 Suppl 1: S19-45. Review.